What Good Bioinformatics Deliverables Actually Look Like (And Why a Folder of CSVs Isn't One)
The analysis can be flawless and the deliverable still unusable. Here's what separates a client-ready bioinformatics deliverable from a data dump — and why it matters for your manuscript.
You can do everything right and still hand over something nobody can use.
The normalization was defensible. The statistics were appropriate. The figures were publication-quality. And yet the project stalls, because what landed in the client’s inbox was a shared drive with forty analysis folders, several hundred CSVs, and no map. Somewhere in there is the answer to the question they actually asked. Good luck finding it.
We’ve seen this from both sides, and on one recent spatial omics project it was stated plainly on a call: “there’s a lot of folders and a lot of data.” That wasn’t a complaint about the science. The science was sound. It was a complaint about the deliverable — and the deliverable is the only part of the work the client ever experiences.
A folder of CSVs is not a deliverable
Here’s how the data-dump problem actually plays out, beyond the inconvenience of too many files.
On that project, the analysis had gone through several variants — a subset of samples here, a corrected grouping there, a different stratification, a re-run after a fix. Each lived in its own folder, and the names grew by accretion: analysis_v2, analysis_v2_filtered, analysis_v2_filtered_groupAvsB, analysis_v2_filtered_groupAvsB_reRun — each suffix marking a parameter change that made sense the day it was added. Reasonable names when you write them. Three weeks later, nobody — including the analyst — can remember which folder used which settings without opening the files and reverse-engineering them.
That ambiguity isn’t cosmetic. It changes conclusions. The same question — do these cells differ by biomarker status? — gave opposite answers depending on whether compartments were pooled or analyzed separately, and the pooled number quietly made it into an abstract draft. When a co-author later went looking for the data behind a stated association, they searched the wrong file and couldn’t find it, because the number had come from a different variant entirely.
So the failure mode of a data dump isn’t just “hard to navigate.” It’s:
- Claims that can’t be traced back to the run that produced them.
- Results that are silently inconsistent across variants nobody can tell apart.
- An analyst rebuilding a data inventory after the fact just to answer “where did this number come from?”
That’s expensive, it’s error-prone, and it shows up at the worst possible time — during manuscript revisions, when a reviewer asks for the source of a specific value.
What a good deliverable actually is
A deliverable isn’t the analysis. It’s the interface to the analysis. Judged that way, a good one has a few properties:
1. It leads with findings, not files. The unit of delivery should be a finding — a figure, a sentence that says what it means, and a link to the data behind it — not a CSV dumped into a directory. The client should open it and immediately see the answer, with the raw data one click away if they want it. Many decision-makers — a busy PI, a clinician co-author — don’t have time to comb through raw CSVs under deadline; they need to see the figure and what it means, with the underlying data right there for whoever does want to dig in. Serve the finding first, without burying the data.
2. Every number is traceable to its source. If a value appears in a report, you should be able to click it and see exactly which analysis run produced it: which input data, which parameters, which samples, which version of the code. This is the single most useful property a deliverable can have, and it’s the one most often missing. It turns “where did this come from?” from an afternoon of archaeology into a click.
3. Context is explicit, never assumed. A correlation or a fold-change shown without its context — which compartment, pooled or compartment-specific, which stratification group — is an invitation to misread it. The deliverable should make the context impossible to lose, and ideally flag the cases (like pooling across compartments) where the framing can mislead. We’ve written before about why data-driven cutoffs beat arbitrary thresholds; the same principle applies to how results are presented, not just computed.
4. Variants are comparable, not scattered. “What changed between run A and run B?” should be answerable by design, not by diffing folder names. When parameter changes are explicit and side-by-side, the pooled-versus-specific trap stops being a trap.
5. It’s reproducible and versioned. A collaborator should be able to regenerate the result, and “the figure in the report” should correspond to a known state of the data and code — not a screenshot from a run that’s since been overwritten.
Notice none of this is about doing more analysis. It’s about packaging the analysis you already did so it survives contact with a busy human.
Why this gets skipped
If it’s so valuable, why is the data dump still the default? Because the incentives push against it. The analyst is measured on getting the analysis right, and by the time it is right, the deadline is here and “packaging” feels like overhead. Curation, provenance, and a clean report are real work that happens after the interesting work is done — so they get compressed, then skipped. This is part of the broader bioinformatician bottleneck: the analysis scales faster than the ability to communicate it.
The honest fix isn’t “try harder to organize the folders.” Folders don’t scale, and discipline erodes under deadline pressure. The fix is to make the deliverable a product of the workflow itself — so that traceability and curation are generated as you analyze, not bolted on at the end. Defining that expectation up front, in the statement of work, is half the battle; building the workflow to produce it is the other half.
How we approach it now
This problem is exactly why we built Cytogence Atlas. Rather than shipping clients a drive full of folders, we deliver through a secure client portal where the output is curated findings — figures and reports with the provenance behind every number a click away, organized by project instead of scattered across variants. We run the analysis; the client logs in and sees the answer, traceable to its source, without us emailing a single zip file.
That delivery layer is live now in an invite-only preview for our clients — focused, today, on getting analysis results into your hands in a form you can actually use and cite. (The broader self-service analysis platform is rolling out behind it.) If you’ve ever lost an afternoon hunting for the file behind a number in your own manuscript, that’s the problem it exists to kill.
The deeper point stands with or without any particular tool: the analysis is only as good as the deliverable that carries it. If your last bioinformatics engagement ended with a folder of CSVs and a vague sense that the answer was in there somewhere, that wasn’t a data problem. It was a delivery problem — and it’s a solvable one.
Cytogence is the bioinformatics division of KeyQ, Inc. We deliver analysis our clients can actually use — curated, traceable, and manuscript-ready. See how Atlas delivers results, or start a conversation about your project.